Cargando…
Galectin-3: a novel biomarker for the prognosis of heart failure
Heart failure (HF) is still a global burden which carries substantial risk of morbidity and mortality. Thus, appropriate approach of diagnosis and layering the prognosis of HF are of great importance. In this paper we discuss and review a novel biomarker, which is called galectin-3 and already appro...
Autores principales: | AMIN, HILMAN ZULKIFLI, AMIN, LUKMAN ZULKIFLI, WIJAYA, IKA PRASETYA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iuliu Hatieganu University of Medicine and Pharmacy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433562/ https://www.ncbi.nlm.nih.gov/pubmed/28559694 http://dx.doi.org/10.15386/cjmed-751 |
Ejemplares similares
-
Tolvaptan: A Novel Diuretic in Heart Failure Management
por: Zulkifli Amin, Hilman, et al.
Publicado: (2016) -
Takotsubo Cardiomyopathy: A Brief Review
por: Amin, Hilman Zulkifli, et al.
Publicado: (2020) -
Link between the Platelet-to-Lymphocyte Ratio and Coronary Artery Disease Severity
por: Zulkifli Amin, Hilman, et al.
Publicado: (2016) -
The New Mayo Clinic Risk Score Characteristics in Acute Coronary Syndrome in Patients Following Percutaneous Coronary Intervention
por: Amin, Lukman Zulkifli, et al.
Publicado: (2017) -
Cytotoxic T Lymphocyte-Associated Antigen-4 Protects Against Angiotensin II-Induced Kidney Injury in Mice
por: Amin, Hilman Zulkifli, et al.
Publicado: (2020)